The role of simulated-experience and descriptive formats on perceiving risks of strong opioids: A randomized controlled trial with chronic noncancer pain patients.
Chronic noncancer pain
Description–experience gap
Drug safety
Risk communication
Risk perception
Strong opioids
Journal
Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
05
02
2021
revised:
30
08
2021
accepted:
04
10
2021
pubmed:
27
10
2021
medline:
1
6
2022
entrez:
26
10
2021
Statut:
ppublish
Résumé
Opioid prescription rates worldwide suggest miscalibrated risk perceptions among those who prescribe, dispense, and take opioids. Findings from cognitive science show that risk perceptions can differ systematically depending on whether people learn about risks by description or experience. We investigated the effects of descriptive and simulated experience risk formats on patients' risk perceptions and behavior regarding long-term strong opioid use. 300 German patients with chronic noncancer pain were randomly assigned in an exploratory randomized controlled trial to either a descriptive format (fact box) or a simulated experience format (interactive simulation). Primary endpoints were subjective and objective risk perceptions and intended intake behavior. Both formats significantly improved patients' objective risk perception; patients who saw the fact box estimated some outcomes more accurately (p = .031). Formats were equally effective in improving patients' subjective risk perception in terms of opioids' harms; however, patients receiving the simulation showed a greater reduction and termination of their opioid intake (p = .030) and a higher uptake of alternative therapies. Descriptive and simulated experience risk formats improve risk perceptions and behavior regarding potent but highly risky drugs. To eliminate risky behavior, simulated experience formats may be superior to descriptive formats.
Identifiants
pubmed: 34696941
pii: S0738-3991(21)00658-3
doi: 10.1016/j.pec.2021.10.002
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1571-1580Informations de copyright
Copyright © 2021. Published by Elsevier B.V.